Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120

Virology
Robert A OgertJohn A Howe

Abstract

Several small molecule drugs that bind to the host CCR5 co-receptor and prevent viral entry have been developed for the treatment of HIV-1 infection. The innate variability found in HIV-1 envelope and the complex viral/cellular interactions during entry makes defining resistance to these inhibitors challenging. Here we found that mapping determinants in the gp160 gene from a primary isolate RU570-VCV(res), selected in culture for resistance to the CCR5 entry inhibitor vicriviroc, was complicated by inactivity of the cloned envelope gene in pseudovirus assays. We therefore recombined the envelope from RU570-VCV(res) into a highly active and susceptible ADA gp160 backbone. The chimeric envelopes generated robust signals in the pseudovirus assay and a 200 amino acid fragment, encompassing a C2-V5 region of the RU570-VCV(res) envelope, was required to confer resistance in both the single-cycle assay and in replicating virus. In contrast, a chimeric envelope that contained only the V3-loop region from this resistant virus was completely susceptible suggesting that the V3-loop changes acquired are context dependent.

References

Jan 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Alexandra TrkolaJohn P Moore
Mar 27, 2004·Current HIV Research·Sean M Philpott
Jan 14, 2005·Current Opinion in Infectious Diseases·Eoin CoakleyJeannette M Whitcomb
Nov 15, 2005·Science·Chih-chin HuangPeter D Kwong
Dec 7, 2005·Antiviral Chemistry & Chemotherapy·Mike Westby, Elna van der Ryst
Sep 9, 2006·Annual Review of Medicine·Athe M N Tsibris, Daniel R Kuritzkes
Jun 16, 2007·The Journal of Infectious Diseases·Roy M GulickUNKNOWN AIDS Clinical Trials Group 5211 Team

❮ Previous
Next ❯

Citations

Jul 17, 2010·Future Microbiology·Tsutomu Murakami, Naoki Yamamoto
Mar 18, 2009·Proceedings of the National Academy of Sciences of the United States of America·Cleo G AnastassopoulouJohn P Moore
Apr 3, 2009·Current Opinion in HIV and AIDS·William C Olson, Jeffrey M Jacobson
Apr 3, 2009·Current Opinion in HIV and AIDS·John P Moore, Daniel R Kuritzkes
Apr 3, 2009·Current Opinion in HIV and AIDS·Donald E Mosier
Nov 19, 2009·Drug Design, Development and Therapy·Neelanjana Ray
Jan 15, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Keith W CrawfordUNKNOWN ACTG A5211 Study Team
Sep 22, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Timothy J HenrichDaniel R Kuritzkes
Sep 10, 2011·AIDS Research and Human Retroviruses·Maria Espirito-SantoJ Miguel Azevedo-Pereira
Jan 25, 2013·Viruses·Christopher J De Feo, Carol D Weiss
Jul 27, 2012·Current Opinion in HIV and AIDS·Stéphanie RaymondJacques Izopet
Apr 2, 2013·Antiviral Research·Aiman A Haqqani, John C Tilton
Mar 19, 2014·Critical Reviews in Microbiology·George Panos, Dionysios Christos Watson
Feb 8, 2013·Viruses·Leonardo Augusto Luvison Araújo, Sabrina E M Almeida
Nov 1, 2008·Expert Opinion on Drug Discovery·Patrick Dorr, Manos Perros
Oct 23, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ulf KarlssonMarianne Jansson
Jul 25, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Paul McNicholasJulie M Strizki
Aug 18, 2009·Antiviral Research·John C Tilton, Robert W Doms
Jun 25, 2013·The Journal of Antimicrobial Chemotherapy·Pierre DelobelJacques Izopet
Jul 3, 2013·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Hongyan GuoXiaohong Kong
Feb 18, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Leonardo Augusto Luvison AraújoSabrina Esteves de Matos Almeida
Feb 10, 2011·Journal of Translational Medicine·Bruce L GilliamRobert R Redfield
May 15, 2016·Biochemical and Biophysical Research Communications·Satoshi TakedaJun Komano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.